“Risk Assessment of Cyclophosphamide and Mycophenolate Mofetil after Induction Treatment of Lupus Nephritis: A Single Center Quasi-Experimental Study”, Chatt Maa Shi Hosp Med Coll J, vol. 22, no. 1, pp. 28–32, Jul. 2023, doi: 10.3329/cmoshmcj.v22i1.67831.